Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioVaxys Technology Corp. BVAXF

Full chart Compare
Set alert

Price alert · BVAXF

All alert types
0.09 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.0677 Day range 0.0677
0.0102 52-week range 0.208
YTD
-46.84%
1 year
-55.47%

Financial health

Altman Z-Score

-49.15 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -3.7×
FY 2018: 0.0×FY 2019: -7.0×FY 2020: -10.7×FY 2021: -4.8×FY 2022: -1.7×FY 2023: -0.3×FY 2024: -3.7×
FY 2018 5y median -3.7× FY 2024
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2018 5y median 0.0× FY 2024
P/B -7.6×
FY 2018: 0.0×FY 2019: 8.5×FY 2020: 1.2×FY 2021: 3.8×FY 2022: -26.3×FY 2023: -0.6×FY 2024: -7.6×
FY 2018 5y median -0.6× FY 2024
P/FCF -5.0×
FY 2018: 0.0×FY 2019: -7.0×FY 2020: -9.6×FY 2021: -5.8×FY 2022: -12.9×FY 2023: -1.9×FY 2024: -5.0×
FY 2018 5y median -5.8× FY 2024
EV/EBITDA 0.0×
FY 2018: 0.0×FY 2019: -7.5×FY 2020: -9.3×FY 2021: -5.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2018 5y median 0.0× FY 2024
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2018 5y median 0.0× FY 2024
FCF Yield -20.1%
FY 2018: 0.0%FY 2019: -14.3%FY 2020: -10.4%FY 2021: -17.2%FY 2022: -7.7%FY 2023: -52.5%FY 2024: -20.1%
FY 2018 5y median -17.2% FY 2024

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024
ROE 206.0%
FY 2018: 0.0%FY 2019: -121.0%FY 2020: -12.3%FY 2021: -79.0%FY 2022: 1516.1%FY 2023: 228.0%FY 2024: 206.0%
FY 2018 5y median 206.0% FY 2024
ROIC 168.6%
FY 2018: 0.0%FY 2019: -69.2%FY 2020: -10.6%FY 2021: -73.1%FY 2022: 491.6%FY 2023: 71.3%FY 2024: 168.6%
FY 2018 5y median 71.3% FY 2024
ROA -304.0%
FY 2018: 0.0%FY 2019: -75.1%FY 2020: -11.2%FY 2021: -75.9%FY 2022: -1354.9%FY 2023: -6774.3%FY 2024: -304.0%
FY 2018 5y median -304.0% FY 2024

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 FY 2024
Operating Income -29.9%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -450.4%FY 2021: -492.5%FY 2022: 36.4%FY 2023: 36.8%FY 2024: -29.9%
FY 2018 FY 2024
EPS (diluted) 64.7%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -262.0%FY 2021: -99.2%FY 2022: -54.0%FY 2023: 52.3%FY 2024: 64.7%
FY 2018 FY 2024
Free Cash Flow -176.7%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -431.7%FY 2021: -331.5%FY 2022: 70.3%FY 2023: 33.0%FY 2024: -176.7%
FY 2018 FY 2024

Financial Health

Current Ratio 0.4×
FY 2018: 0.2×FY 2019: 2.6×FY 2020: 3.4×FY 2021: 2.7×FY 2022: 0.4×FY 2023: 0.0×FY 2024: 0.4×
FY 2018 5y median 0.4× FY 2024
Quick Ratio 0.4×
FY 2018: 0.2×FY 2019: 2.6×FY 2020: 3.4×FY 2021: 2.7×FY 2022: 0.4×FY 2023: 0.1×FY 2024: 0.4×
FY 2018 5y median 0.4× FY 2024
Debt / Equity -0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -0.0×
FY 2018 5y median 0.0× FY 2024
Net Debt / EBITDA 0.0×
FY 2018: 0.0×FY 2019: 1.2×FY 2020: 2.4×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2018 5y median 0.0× FY 2024
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2018 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-10-31